Frédéric Triebel

Frédéric Triebel is Chief Scientific and Medical Officer of Prima Biomed, New South Wales, Australia.

Content by Frédéric Triebel:

 Research Field Cancer

Chasing Checkpoints

| Frédéric Triebel

Therapeutic modulation of checkpoint inhibitors is bringing new treatment to cancer patients
Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist